Thomas Hussenet

Summary

Publications

  1. ncbi An adult tissue-specific stem cell molecular phenotype is activated in epithelial cancer stem cells and correlated to patient outcome
    Thomas Hussenet
    IGBMC, Institut de Genetique et de Biologie Moleculaire et Cellulaire, Département de Biologie du Cancer, CNRS Université de Strasbourg UMR 7104 INSERM U964, Illkirch, France
    Cell Cycle 9:321-7. 2010
  2. ncbi SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas
    Thomas Hussenet
    Département Biologie du Cancer, Institut National de la Sante et de la Recherche Medicale, Institut de Genetique et de Biologie Moleculaire et Cellulaire, U964 Illkirch, France
    PLoS ONE 5:e8960. 2010
  3. ncbi SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis
    Thomas Hussenet
    IGBMC, Institut de Genetique et de Biologie Moleculaire et Cellulaire, Département de Biologie du Cancer, INSERM U964, CNRS Université de Strasbourg UMR 7104, Illkirch, France
    Cell Cycle 9:1480-6. 2010
  4. ncbi Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancer
    Richard Redon
    Institut de Genetique et de Biologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique Institut National de la Santé et de la Recherche Médicale Université Louis Pasteur, F 67404 Illkirch Cedex, France
    Cancer Res 62:6211-7. 2002

Collaborators

  • Doulaye Dembele
  • Richard Redon
  • Bernard Jost
  • Daniele Muller
  • Krishna Caulee
  • Gaétan Bour
  • Stanislas du Manoir
  • Joseph Abecassis

Detail Information

Publications4

  1. ncbi An adult tissue-specific stem cell molecular phenotype is activated in epithelial cancer stem cells and correlated to patient outcome
    Thomas Hussenet
    IGBMC, Institut de Genetique et de Biologie Moleculaire et Cellulaire, Département de Biologie du Cancer, CNRS Université de Strasbourg UMR 7104 INSERM U964, Illkirch, France
    Cell Cycle 9:321-7. 2010
    ....
  2. ncbi SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas
    Thomas Hussenet
    Département Biologie du Cancer, Institut National de la Sante et de la Recherche Medicale, Institut de Genetique et de Biologie Moleculaire et Cellulaire, U964 Illkirch, France
    PLoS ONE 5:e8960. 2010
    ..These results indicate that the SOX2 transcription factor, a major regulator of stem cell function, is also an oncogene and a driver gene for the recurrent 3q26.33 amplifications in lung SCC...
  3. ncbi SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis
    Thomas Hussenet
    IGBMC, Institut de Genetique et de Biologie Moleculaire et Cellulaire, Département de Biologie du Cancer, INSERM U964, CNRS Université de Strasbourg UMR 7104, Illkirch, France
    Cell Cycle 9:1480-6. 2010
    ....
  4. ncbi Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancer
    Richard Redon
    Institut de Genetique et de Biologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique Institut National de la Santé et de la Recherche Médicale Université Louis Pasteur, F 67404 Illkirch Cedex, France
    Cancer Res 62:6211-7. 2002
    ..This cyclin was previously pinpointed as a candidate for a role in promoting cell cycle entry. Thus, we propose cyclin L as a candidate oncogene in head and neck cancer...